Form 57.144 Long-Term Care RTI Module

[NCEZID] The National Healthcare Safety Network (NHSN)

57.144 RP Module Form_ RP update clean

57.144 - Long Term Care Respiratory Tract Infections (RTI) Module

OMB: 0920-0666

Document [docx]
Download: docx | pdf

Form Approved

OMB No. 0920-0666

Exp. Date 12/31/2026

www.cdc.gov/nhsn


*Facility ID:

Event #:

*Resident ID:


Medicare number (or comparable railroad insurance number):

*Resident Name: First: Middle: Last:

*Gender: F M Other

*Date of Birth: ___/___/____

Sex at Birth: F M Other

Gender Identity (Specify):

*Ethnicity (specify): Hispanic or Latino Not Hispanic or Latino

Declined to respond □ Unknown

*Race (specify): American Indian/Alaska Native Asian Black or African American Native Hawaiian/Other Pacific Islander White

Declined to respond □ Unknown


EVENT DETAILS

*Event Type: □ Influenza (flu) □ COVID-19 □ Respiratory Syncytial Virus (RSV)



*Date of Event: __/__/____


*Date of Current Admission to Facility: __/__/____

Resident Respiratory Pathogens Event Form

*VACCINATION STATUS

Indicate the resident’s vaccination status

Has the resident received any influenza (flu) vaccine during the current flu season? □ Yes □ No

If yes, Date of Vaccination: __/__/___

Has the resident received any COVID-19 vaccination? □ Yes □ No

If yes, Date of most recent vaccination: __/__/___

Has the resident received a RSV vaccine? □ Yes □ No

If yes, Date of Vaccination: __/__/___

*ANTIVIRAL TREATMENT

Select one. Include treatment that was received/administered in any location (within the facility or an outside facility) for this positive test result.

  • None



Influenza

  • Oseltamivir (Tamiflu)

  • Zanamivir

  • Peramivir

  • Baloxavir


COVID-19

  • Paxlovid

  • Remdesivir

  • Molnupiravir


**Antiviral treatment start date __/__/____



Assurance of Confidentiality: The voluntarily provided information obtained in this surveillance system that would permit identification of any individual or institution is collected with a guarantee that it will be held in strict confidence, will be used only for the purposes stated, and will not otherwise be disclosed or released without the consent of the individual, or the institution in accordance with Sections 304, 306 and 308(d) of the Public Health Service Act (42 USC 242b, 242k, and 242m(d)). Public reporting burden of this collection of information is estimated to average 25 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering, and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC, Reports Clearance Officer, 1600 Clifton Rd., MS D-74, Atlanta, GA 30333, ATTN: PRA (0920-0666). CDC (form number) Rev v12

*HOSPITALIZATION

*Was the resident hospitalized after this positive test result?

Yes □ No

**Date of hospitalization __/__/____


*DEATH

*Did the resident die in the 30 days after this positive test result?

Yes □ No

**Date of death __/__/____












File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
File TitleCOVID-19 Form Resident Impact and Facility Capacity
SubjectNHSN LTCF COVID-19
AuthorCDC/NCEZID/DHQP
File Modified0000-00-00
File Created2024-11-16

© 2024 OMB.report | Privacy Policy